Kee Song Bio Technology: New KSA Loans Granted to KSR Exceeding NT$10 Million or 2% of Company Net Worth on Latest Financial Statements
Close
Provided by: Kee Song Bio-Technology Holdings Limited |
|||||
SEQ_NO |
1 |
announcement date |
2022/02/07 |
Announcement time |
16:23:05 |
Topic |
KSA new loans extended to KSR exceeding NT$10 million or 2% of the Company's net worth on the latest financial statements |
||||
Date of events |
2022/01/10 |
What item it responds to |
paragraph 23 |
||
Declaration |
1.Date of occurrence of the event:2022/01/10 2.Funding recipient (1)Name(2)Relationship with lender (3)Lending limit (thousand NTD)(4)Starting outstanding balance (thousand NTD)(5)New loan (thousand NTD)(6)Is it part of a scheduled allocation or revolving limit for the same recipient that the chairman is authorized by the board of directors to allocate(7)Outstanding balance (thousand NTD) up to the date of occurrence (8)Reason for new loan (thousand NTD): (1)Name:Kee Song Realty (M) Sdn Bhd (2)Relationship with lender:lending funds between subsidiaries of the Company (3)Lending limit (thousand NTD):74104 (4)Starting outstanding balance (thousand NTD):8644 (5)New loan (thousand NTD):43887 (6)Is it part of a scheduled allocation or revolving limit for the same recipient that the chairman is authorized by the board of directors to allocate:No (7)Outstanding balance (thousand NTD) up to the date of occurrence:52531 (8)Reason for new loan (thousand NTD):working capital needs 3.For collaterals provided by the loan recipient, the (1)Content(2)Value (thousand NTD):(1)Content:None (2)Value (thousand NTD):0 4.For the latest financial reports of the loan recipient, the (1)Capital (thousand NTD)(2)Cumulative gains/losses (thousand NTD):(1)Capital (thousand NTD):7500 (2)Cumulative gains/losses (thousand NTD):-3 5.Method of calculation of interest:bank interest rates 6.For repayment, the(1)Condition(2)Date: (1)Condition:5 years (2)Date:By January 9, 2027 7.The amount of monetary loans extended to others as of the date of occurrence (thousand NTD):163564 8.The total amount of monetary loans extended to others as a percentage of the public company��s net worth on the latest financial statements as of the date of occurrence:31.27 9.Sources of funds for the company to extend monetary loans to others:Self funding 10.Any other matters that need to be specified:None |
Warning
Kee Song Bio-Technology Holdings Ltd. published this content on February 07, 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unmodified, on February 07, 2022 08:37:05 UTC.
Public now 2022
|
|
|
|
|
||||
|
||||
Evolution of the income statement
Comments are closed.